Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gastroenterology

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2014.04.035PMID 24786893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New horizons in hepatitis C antiviral therapy with direct‐acting antivirals

  2013cited by this paper
• Current and future therapies for hepatitis C virus infection.

  2013cited by this paper
• 833 DOWN-REGULATION OF INTERFERON-STIMULATED GENES AFTER ALISPORIVIR INTERFERON-FREE TREATMENT SUGGESTS A UNIQUE ANTIVIRAL MECHANISM OF ACTION FOR ALISPORIVIR, A CYCLOPHILIN INHIBITOR

  2013cited by this paper
• Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

  2013cited by this paper
• Treatment of chronic hepatitis C: current and future.

  2013cited by this paper
• Sofosbuvir for previously untreated chronic hepatitis C infection.

  2013cited by this paper
• Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?

  2013cited by this paper
• The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes

  2012cited by this paper
• Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.

  2012cited by this paper
• Stress granules contribute to α-globin homeostasis in differentiating erythroid cells.

  2012cited by this paper
• The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection.

  2012cited by this paper
• dsRNA-Dependent Protein Kinase PKR and its Role in Stress, Signaling and HCV Infection

  2012cited by this paper
• Interferons and hepatitis C virus.

  2012cited by this paper
• New targets for antiviral therapy of chronic hepatitis C

  2012cited by this paper
• The science of direct-acting antiviral and host-targeted agent therapy.

  2012cited by this paper
• Hepatitis C Virus (HCV) Induces Formation of Stress Granules Whose Proteins Regulate HCV RNA Replication and Virus Assembly and Egress

  2012cited by this paper
• Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection.

  2012cited by this paper
• Treatment failure and resistance with direct‐acting antiviral drugs against hepatitis C virus

  2011cited by this paper
• A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach

  2010cited by this paper
• Hepatitis C Virus Controls Interferon Production through PKR Activation

  2010cited by this paper
• Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus*

  2010cited by this paper
• Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A.

  2010cited by this paper
• Identification of cellular and viral factors related to anti‐hepatitis C virus activity of cyclophilin inhibitor

  2009cited by this paper
• The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment‐naïve hepatitis C patients

  2009cited by this paper
• The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication*

  2009cited by this paper
• Cyclophilin inhibitors.

  2009cited by this paper
• Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics

  2009cited by this paper
• Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B*

  2009cited by this paper
• Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus

  2009cited by this paper
• Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.

  2009cited by this paper
• Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.

  2009cited by this paper
• Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

  2008cited by this paper
• Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro

  2008cited by this paper
• What is on the horizon for treatment of chronic hepatitis C?

  2008cited by this paper
• Regulation of innate immunity against hepatitis C virus infection

  2007cited by this paper
• Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia

  2007cited by this paper
• Cyclophilin and Viruses: Cyclophilin as a Cofactor for Viral Infection and Possible Anti-Viral Target

  2007cited by this paper
• In Vitro Infection of Immortalized Primary Hepatocytes by HCV Genotype 4a and Inhibition of Virus Replication by Cyclosporin

  2007cited by this paper
• Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

  2006cited by this paper
• NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

  2006cited by this paper
• VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

  2006cited by this paper
• Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.

  2006cited by this paper
• Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I

  2005cited by this paper
• Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

  2004cited by this paper
• Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial.

  2003cited by this paper
• Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

  2003cited by this paper
• Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

  2003cited by this paper
• Signalling through nuclear receptors

  2002cited by this paper
• Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A

  2002cited by this paper
• Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D.

  2001cited by this paper
• Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

  1999cited by this paper
• Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation

  1998cited by this paper

• IFN alpha inducible protein 27 (IFI27) acts as a positive regulator of PACT-dependent PKR activation after RNA virus infections

  2025cites this paper
• Emerging roles of stress granules in liver diseases: a comprehensive review

  2025cites this paper
• Cyclophilin inhibition as a strategy for the treatment of human disease

  2024cites this paper
• Mammalian integrated stress responses in stressed organelles and their functions

  2024cites this paper
• Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageing

  2024cites this paper
• Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers

  2024cites this paper
• Emerging Roles of Cyclophilin A in Regulating Viral Cloaking

  2022influential citation
• Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches

  2021influential citation
• Neoechinulins: Molecular, cellular, and functional attributes as promising therapeutics against cancer and other human diseases.

  2021cites this paper
• Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease

  2021cites this paper
• Hepatitis C virus exploits cyclophilin A to evade PKR

  2020influential citation
• ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A

  2020cites this paper
• Efficacy and safety of alisporivir for the treatment of hepatitis C infection

  2019cites this paper
• Host-targeting therapies for hepatitis C virus infection: current developments and future applications

  2018cites this paper
• Emerging Antivirals in the Future

  2017cites this paper
• Chaperones in hepatitis C virus infection 2016 Advances in Hepatitis C Virus

  2016cites this paper
• Immunoproteasome induction is suppressed in hepatitis C virus-infected cells in a protein kinase R-dependent manner

  2016cites this paper
• Chaperones in hepatitis C virus infection.

  2016cites this paper
• Interplay between Inflammation and Cellular Stress Triggered by Flaviviridae Viruses

  2016cites this paper
• Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System

  2016cites this paper
• Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance

  2016cites this paper
• Stress Granules Regulate Double-Stranded RNA-Dependent Protein Kinase Activation through a Complex Containing G3BP1 and Caprin1

  2015cites this paper
• Hepatitis C virus NS5A: enigmatic but still promiscuous 10 years on!

  2015influential citation
• Identification and characterisation of small molecule inhibitors targeted to the hepatitis C virus NS2 autoprotease.

  2014cites this paper